Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Liposomal Targeted Delivery Overcomes Immunostimulatory Effects of Oligonucleotide Based Therapy In Chronic Lymphocytic Leukemia.

Bo Yu, Yicheng Mao, Li-Yuan Bai, Sarah E.M. Herman, Asha Ramanunni, Yan Jin, Xiaokui Mo, PhD, Carolyn Cheney, Kenneth K. Chan, PhD, David Jarjoura, Guido Marcucci, MD, Robert Lee, L.James Lee, John C. Byrd, MD, Natarajan Muthusamy, DVM, PhD

Blood (2010) 116 (21): 1475.

https://doi.org/10.1182/blood.V116.21.1475.1475

Published: 2010

Journal Articles

A Novel 2′-Deoxy-2′-Fluoro (2′F-ANA) Ribose Modification Significantly Enhances the Duration, and Efficiency, of Nucleic Acid Mediated Gene Silencing.

Anna Kalota, MS, Lidia Karabon, PhD, Cezary S. Swider, PhD, Ekaterina Viazovkina, PhD, Mohamed Elzagheid, PhD, Masad J. Damha, PhD, Alan M. Gewirtz, MD

Blood (2005) 106 (11): 3062.

https://doi.org/10.1182/blood.V106.11.3062.3062

Published: 2005

Journal Articles

Inhibition of Bcl-2 by Anti-Sense Oligonucleotide and siRNA in Specimens from Patients with Waldenström’s Macroglobulinemia (WM).

Gwen L. Nichols, M.D., Luba Benimetskaya, Ph.D., Cy A. Stein, M.D.Ph.D.

Blood (2004) 104 (11): 2294.

https://doi.org/10.1182/blood.V104.11.2294.2294

Published: 2004

Journal Articles

Enhanced Growth Suppression of Philadephia 1 Leukemia Cells in Mice by Targeting Both BCR-ABL and VEGF through the Antisense Strategy.

Zhong Chao Han, MD, Xiu Li Cong, Bin Li, Ren Chi Yang

Blood (2004) 104 (11): 5257.

https://doi.org/10.1182/blood.V104.11.5257.5257

Published: 2004

Journal Articles

Use of RNA Interference to Inhibit Integrin Subunit alphaV-Mediated Angiogenesis.

Thorsten T. Graef, MD, Ulrich U. Steidl, MD, Roland R. Fenk, MD, Ulrich U. Rohr, MD, Wolfgang W. Nedbal, MD, Rainer R. Haas, MD, Ralf R. Kronenwett, MD

Blood (2004) 104 (11): 5258.

https://doi.org/10.1182/blood.V104.11.5258.5258

Published: 2004

Journal Articles

Effect of hTR Antisense Oligodeoxynucleotides on Telomerase Acitvity and Ciplatin -Sensitivity of Primary Acute Leukemia Cells.

Yang Xiao, MD

Blood (2004) 104 (11): 4359.

https://doi.org/10.1182/blood.V104.11.4359.4359

Published: 2004

Journal Articles

Potentiation of dexamethasone-, paclitaxel-, and Ad-p53–induced apoptosis by Bcl-2 antisense oligodeoxynucleotides in drug-resistant multiple myeloma cells: Presented in abstract form at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 10, 2001. 33

Qun Liu, Yair Gazitt

Blood (2003) 101 (10): 4105–4114.

https://doi.org/10.1182/blood-2002-10-3067

Published: 2003

Journal Articles

Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1

Andreas H. Wagner, Matthias Gebauer, Beatrix Pollok-Kopp, Markus Hecker

Blood (2002) 99 (2): 520–525.

https://doi.org/10.1182/blood.V99.2.520

Published: 2002

Journal Articles

Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides

Corinne Capoulade, Lluis M. Mir, Karine Carlier, Yann Lécluse, Cécile Tétaud, Zohair Mishal, Joëlle Wiels

Blood (2001) 97 (4): 1043–1049.

https://doi.org/10.1182/blood.V97.4.1043

Published: 2001

Journal Articles

Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells

Dale A. Moulding, Richard V. Giles, David G. Spiller, Michael R. H. White, David M. Tidd, Steven W. Edwards

Blood (2000) 96 (5): 1756–1763.

https://doi.org/10.1182/blood.V96.5.1756

Published: 2000

Journal Articles

Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins

Marina Konopleva, Ana M. Tari, Zeev Estrov, David Harris, Zhong Xie, Shourong Zhao, Gabriel López-Berestein, Michael Andreeff

Blood (2000) 95 (12): 3929–3938.

https://doi.org/10.1182/blood.V95.12.3929

Published: 2000

Journal Articles

Characterization of HOX Gene Expression During Myelopoiesis: Role of HOX A5 in Lineage Commitment and Maturation

John F. Fuller, Jeanne McAdara, Yifah Yaron, Mark Sakaguchi, John K. Fraser, Judith C. Gasson

Blood (1999) 93 (10): 3391–3400.

https://doi.org/10.1182/blood.V93.10.3391.410k26_3391_3400

Published: 1999

Journal Articles

BCR-ABL Antisense Oligodeoxynucleotide In Vitro Purging and Autologous Bone Marrow Transplantation for Patients With Chronic Myelogenous Leukemia in Advanced Phase

Paolo de Fabritiis, Maria Concetta Petti, Enrico Montefusco, Maria Stefania De Propris, Roberta Sala, Roberto Bellucci, Marco Mancini, Alessandro Lisci, Francesco Bonetto, Tim Geiser, Bruno Calabretta, Franco Mandelli

Blood (1998) 91 (9): 3156–3162.

https://doi.org/10.1182/blood.V91.9.3156

Published: 1998

Journal Articles

Inhibition of BCR-ABL Expression With Antisense Oligodeoxynucleotides Restores β1 Integrin-Mediated Adhesion and Proliferation Inhibition in Chronic Myelogenous Leukemia Hematopoietic Progenitors

Ravi Bhatia, Catherine M. Verfaillie

Blood (1998) 91 (9): 3414–3422.

https://doi.org/10.1182/blood.V91.9.3414

Published: 1998

Journal Articles

MDM2 Protein Overexpression Promotes Proliferation and Survival of Multiple Myeloma Cells

Gerrard Teoh, Mitsuyoshi Urashima, Atsushi Ogata, Dharminder Chauhan, James A. DeCaprio, Steven P. Treon, Robert L. Schlossman, Kenneth C. Anderson

Blood (1997) 90 (5): 1982–1992.

https://doi.org/10.1182/blood.V90.5.1982

Published: 1997

Journal Articles

Electroporation of synthetic oligodeoxynucleotides: a novel technique for ex vivo bone marrow purging

R Bergan, F Hakim, GN Schwartz, E Kyle, R Cepada, JM Szabo, D Fowler, R Gress, L Neckers

Blood (1996) 88 (2): 731–741.

https://doi.org/10.1182/blood.V88.2.731.bloodjournal882731

Published: 1996

NARROW

Liposomal Targeted Delivery Overcomes Immunostimulatory Effects of Oligonucleotide Based Therapy In Chronic Lymphocytic Leukemia.

A Novel 2′-Deoxy-2′-Fluoro (2′F-ANA) Ribose Modification Significantly Enhances the Duration, and Efficiency, of Nucleic Acid Mediated Gene Silencing.

Inhibition of Bcl-2 by Anti-Sense Oligonucleotide and siRNA in Specimens from Patients with Waldenström’s Macroglobulinemia (WM).

Enhanced Growth Suppression of Philadephia 1 Leukemia Cells in Mice by Targeting Both BCR-ABL and VEGF through the Antisense Strategy.

Use of RNA Interference to Inhibit Integrin Subunit alphaV-Mediated Angiogenesis.

Effect of hTR Antisense Oligodeoxynucleotides on Telomerase Acitvity and Ciplatin -Sensitivity of Primary Acute Leukemia Cells.

Potentiation of dexamethasone-, paclitaxel-, and Ad-p53–induced apoptosis by Bcl-2 antisense oligodeoxynucleotides in drug-resistant multiple myeloma cells: Presented in abstract form at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 10, 2001. 33

Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1

Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides

Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells

Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins

Characterization of HOX Gene Expression During Myelopoiesis: Role of HOX A5 in Lineage Commitment and Maturation

BCR-ABL Antisense Oligodeoxynucleotide In Vitro Purging and Autologous Bone Marrow Transplantation for Patients With Chronic Myelogenous Leukemia in Advanced Phase

Inhibition of BCR-ABL Expression With Antisense Oligodeoxynucleotides Restores β1 Integrin-Mediated Adhesion and Proliferation Inhibition in Chronic Myelogenous Leukemia Hematopoietic Progenitors

MDM2 Protein Overexpression Promotes Proliferation and Survival of Multiple Myeloma Cells

Electroporation of synthetic oligodeoxynucleotides: a novel technique for ex vivo bone marrow purging

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only